For: | Xu J, Wang Q, Song YF, Xu XH, Zhu H, Chen PD, Ren YP. Long noncoding RNA X-inactive specific transcript regulates NLR family pyrin domain containing 3/caspase-1-mediated pyroptosis in diabetic nephropathy. World J Diabetes 2022; 13(4): 358-375 [PMID: 35582664 DOI: 10.4239/wjd.v13.i4.358] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v13/i4/358.htm |
Number | Citing Articles |
1 |
Zhuanli Zhou, Qin Li. The Role of Pyroptosis in the Pathogenesis of Kidney Diseases. Kidney Diseases 2023; 9(6): 443 doi: 10.1159/000531642
|
2 |
Yanchuan Li, Yanfeng Liu, Xiao Yao, Haili Wang, Ziyun Shi, Meiqing He. METTL14‐mediated lncRNA XIST silencing alleviates GDM progression by facilitating trophoblast cell proliferation and migration via the miR‐497‐5p/FOXO1 axis. Journal of Biochemical and Molecular Toxicology 2024; 38(1) doi: 10.1002/jbt.23621
|
3 |
Wei Liu, MengDi Hu, Le Wang, Hamed Mirzaei. Kidney Injury: Focus on Molecular Signaling Pathways. Current Medicinal Chemistry 2024; 31(28): 4510 doi: 10.2174/0109298673271547231108060805
|
4 |
Jiayi Wan, Dongwei Liu, Shaokang Pan, Sijie Zhou, Zhangsuo Liu. NLRP3-mediated pyroptosis in diabetic nephropathy. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.998574
|
5 |
Habib Haybar, Ehsan Sarbazjoda, Daryush Purrahman, Mohammad Reza Mahmoudian-Sani, Najmaldin Saki. The prognostic potential of long noncoding RNA XIST in cardiovascular diseases: a review. Personalized Medicine 2024; 21(4): 257 doi: 10.1080/17410541.2024.2360380
|
6 |
Yan Wang, Zhun Sui, Mi Wang, Peng Liu. Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1196016
|
7 |
Jie Gao, Zhao Gao. The regulatory role and mechanism of USP14 in endothelial cell pyroptosis induced by coronary heart disease. Clinical Hemorheology and Microcirculation 2024; 86(4): 495 doi: 10.3233/CH-232003
|
8 |
Qizhuo Hou, Bin Yi. The role of long non‐coding RNAs in the development of diabetic kidney disease and the involved clinical application. Diabetes/Metabolism Research and Reviews 2024; 40(4) doi: 10.1002/dmrr.3809
|
9 |
Bilgesu Şafak Tümerdem, Tayfun Hilmi Akbaba, Ezgi Deniz Batu, Yeliz Z. Akkaya-Ulum, Pelin Mutlu, Seza Ozen, Banu Balci-Peynircioğlu. Drug metabolism and inflammation related distinct miRNA signature of colchicine resistant familial Mediterranean fever patients. International Immunopharmacology 2023; 124: 111011 doi: 10.1016/j.intimp.2023.111011
|
10 |
Hui Li, Jian Hao, Weimin Yu. LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424. Open Medicine 2023; 18(1) doi: 10.1515/med-2023-0710
|